- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05724823
Virtuelle körperliche Aktivität Sitzübung - Phase 2 (V-PASE)
Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design
This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.
Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.
Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 2G9
- GF Strong Rehabilitation Centre
-
-
Manitoba
-
Winnipeg, Manitoba, Kanada
- University of Manitoba
-
-
Nova Scotia
-
Halifax, Nova Scotia, Kanada
- Nova Scotia Health
-
-
Ontario
-
London, Ontario, Kanada
- Western University
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Kanada
- University of Saskatchewan
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Participants must meet the following inclusion criteria:
- Adult (as defined by Province)
- Chronic stroke (more than 6 months post-stroke)
- Ability to stand up from a chair
- Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
- Able to safely engage in exercise and tolerate 60 minutes of exercises
- Able to communicate in English
- Have access to a tablet, computer, or laptop with internet and email access
Exclusion Criteria:
Participants will be excluded if they meet any of the following criteria:
- Participating in formal exercise or rehabilitation activities
- Participating in > 30 minutes/day of physical activity (moderate intensity)
- Participating in another study that may affect outcomes to this study
- Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
- A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
- Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: 10-week group
Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration. |
The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor. |
|
Kein Eingriff: Delayed 2-week group (Boot Camp)
The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
30 Second Sit-to-Stand
Zeitfenster: Immediately post-intervention (following 10-week trial)
|
Assessment of balance and lower extremity strength. |
Immediately post-intervention (following 10-week trial)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Timed Up and Go
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Tandem Stance
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Measures balance in standing as reported in the Short Physical Performance Battery Protocol |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Modified Telehealth Fugl-Meyer
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Stroke Impact Scale
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item. |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Activities-Specific Balance Confidence (ABC)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy). |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Fatigue Severity Scale
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement). |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Quality of Life (EQ-5D-5L)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health). |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Patient Health Questionnaire-4 (PHQ-4)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day). |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Montreal Cognitive Assessment scale (MoCA-BLIND)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments). |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Lipid Profiles
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Blood samples will be collected following a 12-hour over-night fast |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Fasting Glucose
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Blood samples will be collected following a 12-hour over-night fast |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
Glucose (HbA1c)
Zeitfenster: Immediately post-intervention, and retention (2-months post-intervention)
|
Blood samples will be collected following a 12-hour over-night fast |
Immediately post-intervention, and retention (2-months post-intervention)
|
|
30 Second Sit-to-Stand
Zeitfenster: Retention (2-months post-intervention)
|
Assessment of balance and lower extremity strength. |
Retention (2-months post-intervention)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Feasibility Indicator: Compliance
Zeitfenster: Through study completion (approximately 10 weeks)
|
Percentage of participants that attend exercise sessions. |
Through study completion (approximately 10 weeks)
|
|
Feasibility Indicator: Safety
Zeitfenster: Through study completion (approximately 10 weeks)
|
Number of adverse events that occur during assessments or exercise sessions. |
Through study completion (approximately 10 weeks)
|
Mitarbeiter und Ermittler
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- H22-02549
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .